Vik Chopra

Stock Analyst at Wells Fargo

(0.43)
# 2728
Out of 5,441 analysts
51
Total ratings
Success rate
Average return
13 Stocks
Name Action PT Current % Upside Ratings Updated
NPCE NeuroPace
Maintains: Overweight
17 15
8.86 69.3% 3 Aug 13, 2025
GMED Globus Medical
Maintains: Overweight
76 66
59.45 11.02% 10 Aug 8, 2025
ENOV Enovis
Maintains: Overweight
48 41
28.13 45.75% 4 Aug 8, 2025
SOLV Solventum
Maintains: Equal-Weight
75 79
71.88 9.91% 4 Aug 8, 2025
XRAY Dentsply Sirona
Maintains: Equal-Weight
16 15
12.52 19.81% 3 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 19
20.19 -5.89% 3 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
246 199
134.92 47.49% 3 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
205 190
147.42 28.88% 9 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
25 13
12.75 1.96% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
80 75
66.11 13.45% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
70 57
52.48 8.61% 5 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
26 19
15.31 24.1% 1 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
47 58
39.75 45.21% 2 Feb 10, 2023